Stay updated on Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The Study Record Dates now display 'Results Submitted' instead of 'No Results Posted', indicating that results have been submitted.
    Difference
    0.1%
    Check dated 2026-02-18T07:52:49.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    An update adds a new footer revision tag 'Revision: v3.4.2' and removes an outdated 'Notice' about government funding as well as the prior 'Revision: v3.4.1' tag. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:00:49.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and NIH Clinical Center operations was added, and the site revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:44:54.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI updates include showing the glossary toggle and new metadata labels (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0), while the corresponding older labels (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T04:52:58.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 appears in the page footer replacing the previous v3.3.3. The update does not alter study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-01-14T02:55:02.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Locations section listing Texas as the study site. Removed the HHS Vulnerability Disclosure footer and updated the page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T14:30:56.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.